Nomura Asset Management Co. Ltd. boosted its position in shares of Cencora, Inc. (NYSE:COR – Free Report) by 7.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 76,185 shares of the company’s stock after purchasing an additional 5,024 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Cencora were worth $25,731,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in the company. Oakworth Capital Inc. bought a new stake in Cencora during the 4th quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new position in Cencora in the fourth quarter worth $27,000. Archer Investment Corp boosted its stake in Cencora by 134.3% in the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after purchasing an additional 47 shares in the last quarter. IAG Wealth Partners LLC bought a new stake in shares of Cencora during the third quarter worth $30,000. Finally, Caitlin John LLC acquired a new stake in shares of Cencora in the third quarter valued at $31,000. 97.52% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of research analysts recently issued reports on the company. UBS Group lifted their price target on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Citigroup lowered their price objective on shares of Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Evercore set a $360.00 target price on shares of Cencora in a research report on Wednesday, April 8th. Weiss Ratings cut shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, May 22nd. Finally, Robert W. Baird lowered their price target on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a report on Thursday, May 7th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Cencora has a consensus rating of “Moderate Buy” and an average target price of $380.25.
Cencora Stock Performance
Shares of Cencora stock opened at $265.09 on Tuesday. Cencora, Inc. has a 52 week low of $244.82 and a 52 week high of $377.54. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. The stock has a market capitalization of $51.58 billion, a price-to-earnings ratio of 20.33, a PEG ratio of 1.24 and a beta of 0.59. The firm has a fifty day moving average of $297.22 and a two-hundred day moving average of $332.99.
Cencora (NYSE:COR – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The company had revenue of $78.36 billion for the quarter, compared to analyst estimates of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same period last year, the firm earned $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities research analysts predict that Cencora, Inc. will post 17.79 EPS for the current year.
Cencora declared that its Board of Directors has initiated a stock repurchase plan on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to buy up to 3.9% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s leadership believes its shares are undervalued.
Cencora Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were paid a $0.60 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.9%. Cencora’s dividend payout ratio is 18.40%.
Cencora Profile
Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.
Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.
Featured Stories
- Five stocks we like better than Cencora
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:COR – Free Report).
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
